Results 211 to 220 of about 15,593,409 (387)

P717: AG946, A PYRUVATE KINASE (PK) ACTIVATOR IMPROVES PK PROPERTIES AND RED BLOOD CELL (RBC) METABOLISM UPON EX VIVO TREATMENT OF RBCS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES

open access: yesHemaSphere, 2023
Jonathan de Wilde   +9 more
doaj   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner   +6 more
wiley   +1 more source

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

open access: yesMolecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul   +11 more
wiley   +1 more source

Blood-volume measurements in cancer using the Cr51 red-blood-cell tagging method [PDF]

open access: bronze, 1956
William A. Reilly   +2 more
openalex   +1 more source

Correction to: BET protein inhibition regulates cytokine production and promotes neuroprotection after spinal cord injury

open access: yesJournal of Neuroinflammation, 2022
Judith Sánchez-Ventura   +3 more
doaj   +1 more source

Red cell distribution width, haemoglobin A1c and incidence of diabetes mellitus

open access: yesJournal of Internal Medicine, 2014
Gunnar Engström   +5 more
semanticscholar   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

open access: yesMolecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef   +10 more
wiley   +1 more source

The Crescent and the Red Cell

open access: green, 1924
J. W. W. Stephens, R. M. Gordon
openalex   +2 more sources

Home - About - Disclaimer - Privacy